FDA: Approval of ReGen’s Menaflex Knee Device Should be Re-Evaluated
November 16, 2009 by Beckers ASC Review
Filed under Becker's ASC Review, Featured Products
FDA approval of ReGen Biologics’ Menaflex knee device needs to be completely re-evaluated, according to a new FDA preliminary report.
The report said there wasn’t enough evidence to dispel questions about outside influence on the approval, which was granted in December 2008.
It reported “multiple departures from processes, procedures and practices” in the approval process, adding that FDA reviewers had failed to document the reasons why.
The FDA also recently announced that it is reviewing its whole rapid-approval process for medical devices, which is the route that ReGen’s device took.
Read the FDA’s preliminary report on ReGen Biologics’ Menaflex knee device (pdf).
If you enjoyed this post, make sure you subscribe to my RSS feed!
 |
A post by "Becker's ASC Editor" http://www.beckersasc.com Becker's ASC Review is a bimonthly publication that offers general business, legal and clinical guidance on topics including joint-ventures, development and expansion, and regulatory and compliance issues. |
